256. 筋型糖原病 Muscle glycogenosis Clinical trials / Disease details
臨床試験数 : 180 / 薬物数 : 153 - (DrugBank : 30) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 134
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04094948 (ClinicalTrials.gov) | January 1, 2023 | 17/9/2019 | Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease | Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease Stably Treated With Enzyme Replacement Therapy | Pompe Disease (Late-onset) | Drug: Clenbuterol;Drug: Placebos | Duke University | NULL | Not yet recruiting | 18 Years | N/A | All | 40 | Phase 2 | United States |
2 | NCT01942590 (ClinicalTrials.gov) | September 2013 | 11/9/2013 | Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy | A Clinical Investigation of the Safety and Efficacy of Clenbuterol on Motor Function in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy | Pompe Disease | Drug: Clenbuterol;Drug: Placebo | Dwight Koeberl, M.D., Ph.D. | NULL | Completed | 18 Years | N/A | All | 17 | Phase 1/Phase 2 | United States |